Company Filing History:
5 out of 10 
1 out of 1 Years Active: 2017-2023
Title: Maria Obdulia Rabal Gracia: Innovator in Cancer Treatment
Introduction
Maria Obdulia Rabal Gracia is a prominent inventor based in Pamplona, Spain. She has made significant contributions to the field of medical research, particularly in the development of innovative peptides for cancer treatment. With a total of six patents to her name, her work is paving the way for advancements in therapeutic approaches.
Latest Patents
One of her latest patents is focused on FOXP3-binding peptides and their uses. The invention provides peptides of a specific general formula, which are designed to bind and inhibit FoxP3. These peptides are highly efficient in blocking Treg cell functionality, making them valuable in cancer treatment. The patent also includes constructs comprising the peptide and various combinations that enhance its therapeutic potential.
Career Highlights
Maria has worked with notable organizations such as Fundación para la Investigación Médica Aplicada and Fundación La Investigación Médica Aplicada. Her work in these institutions has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of her coworkers include Julen Oyarzabal Santamarina and María Del Mar Cuadrado Tejedor. Their collaborative efforts have further enriched the research environment and fostered innovation in medical applications.
Conclusion
Maria Obdulia Rabal Gracia is a trailblazer in the field of cancer research, with her innovative peptides offering new hope for treatment. Her contributions and collaborations continue to inspire advancements in medical science.